Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations

MLA

Roberto Ruiz-Cordero, et al. “Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 Mutations.” BMC Cancer, vol. 20, no. 1, Jan. 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12885-020-6579-z.

APA

Roberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, Genevieve Lyons, Waree Rinsurongkawong, Roland Bassett, Ming Guo, Mark J. Routbort, Jianjun Zhang, Ferdinandos Skoulidis, John Heymach, Emily B. Roarty, Zhenya Tang, L. Jeffrey Medeiros, Keyur P. Patel, Rajyalakshmi Luthra, & Sinchita Roy-Chowdhuri. (2020). Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations. BMC Cancer, 20(1), 1–11. https://doi.org/10.1186/s12885-020-6579-z

Chicago

Roberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, Genevieve Lyons, Waree Rinsurongkawong, Roland Bassett, Ming Guo, et al. 2020. “Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 Mutations.” BMC Cancer 20 (1): 1–11. doi:10.1186/s12885-020-6579-z.